Dartmouth Health Continuing Education for Professionals Home, Medicine Grand Rounds - Discovering VEXAS: the Science of Team Science, 7/16/2021 8:00:00 AM - 7/16/2024 9:00:00 AM, Participants in Medicine Grand Rounds will be able to identify the most current treatment guidelines, innovations, and standards of practice, and apply them to improve the care of individual patients, promote health and wellness in the population, and achieve clinical quality and safety goals. These educational activities are grounded in principles of health equity, evidence based medicine, inter-professional teamwork, patient-centered care, and respect for human dignity.
Presenter
Peter Grayson, MD, MSc
Tenure Track Investigator
National Institutes of Health
Founder and Principle Investigator, Vasculitis Translational Research Program
Associate Director NIAMS Rheumatology Fellowship Program
About our Presenter
Dr. Grayson is board-certified in Internal Medicine and Rheumatology. He earned his undergraduate degree from Brown University and his medical degree from the Medical University of South Carolina. He completed a Master of Science in Epidemiology at Boston University, where he also trained as a resident, chief resident, and fellow in rheumatology, and went on to complete an additional two-year vasculitis fellowship from within the Vasculitis Clinical Research Consortium.
Learning Outcome(s)
Participants will be able to recognize the clinical features and pathogenetic mechanisms of the VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome, a newly identified monogenic disease of adulthood caused by somatic mutations in UBA1 in hematopoietic progenitor cells.
Disclosure
In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.
The following Activity Physician Director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have reported the following financial interest or relationship* with various companies/organizations. The Planning Committee member role was resolved by altering the individual’s control over content about the products or services of the commercial interest by Marc Bertrand, MD, Associate Dean for GME (as alternate for vacant Associate Dean for CME position). All potential conflict(s) were resolved.
* Richard I. Rothstein, MD ~ has research support from Fractyl and is on the Scientific Advisory Board for Allurion.
Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this program report no financial interest or relationship* with any company(ies) or organizations whose product may be germane to the content of their presentations.
*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.
Bibliographic Material
See presentation for bibliographic sources to allow for further study.
Presenter
Peter Grayson, MD, MSc
Tenure Track Investigator
National Institutes of Health
Founder and Principle Investigator, Vasculitis Translational Research Program
Associate Director NIAMS Rheumatology Fellowship Program
About our Presenter
Dr. Grayson is board-certified in Internal Medicine and Rheumatology. He earned his undergraduate degree from Brown University and his medical degree from the Medical University of South Carolina. He completed a Master of Science in Epidemiology at Boston University, where he also trained as a resident, chief resident, and fellow in rheumatology, and went on to complete an additional two-year vasculitis fellowship from within the Vasculitis Clinical Research Consortium.
Learning Outcome(s)
Participants will be able to recognize the clinical features and pathogenetic mechanisms of the VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome, a newly identified monogenic disease of adulthood caused by somatic mutations in UBA1 in hematopoietic progenitor cells.
Disclosure
In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.
The following Activity Physician Director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have reported the following financial interest or relationship* with various companies/organizations. The Planning Committee member role was resolved by altering the individual’s control over content about the products or services of the commercial interest by Marc Bertrand, MD, Associate Dean for GME (as alternate for vacant Associate Dean for CME position). All potential conflict(s) were resolved.
* Richard I. Rothstein, MD ~ has research support from Fractyl and is on the Scientific Advisory Board for Allurion.
Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this program report no financial interest or relationship* with any company(ies) or organizations whose product may be germane to the content of their presentations.
*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.
Bibliographic Material
See presentation for bibliographic sources to allow for further study.
